Skip to main content

Sjögren’s Syndrome in China

  • Chapter
  • First Online:
  • 1508 Accesses

Abstract

Primary Sjögren’s syndrome (pSS) is as commonly seen in Chinese as in people of other ethnic origins. Previous studies have suggested that Chinese pSS patients may have more severe disease and a higher frequency of major organ involvement, including the cardiac, pulmonary, and neurological diseases. Protein-losing enteropathy, in particular, appears to be a characteristic variant of gastrointestinal disease seen in Chinese patients. As with all patients, keratoconjunctivitis sicca and xerostomia have a major impact in Chinese patients with pSS. This is particularly important for patients from China and other Asian countries because of the lack of a comprehensive dental health service and habitual smoking among patients.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Zeng QY, Chen R, Darmawan J, et al. Rheumatic diseases in China. Arthritis Res Ther. 2008;10:R17. Epub 2008 Jan 31.

    Article  PubMed  Google Scholar 

  2. Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int. 2009;29(5):481–90.

    Article  PubMed  Google Scholar 

  3. Cohen MG, Li EK, Ng PY, Chan KL. Extra-articular manifestations are uncommon in southern Chinese with rheumatoid arthritis. Brit J Rheumatol. 1993;32:209–11.

    Article  CAS  Google Scholar 

  4. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis. 2002;61:554–8.

    Article  PubMed  CAS  Google Scholar 

  5. Zhao Y, Kang J, Zheng WJ, et al. Evaluation of International Classification Criteria (2002) for primary Sjögren’s syndrome in Chinese patients. Chin Med Sci J. 2005;20:190–3.

    PubMed  Google Scholar 

  6. AP Huo, KC Lin, CT Chou. Predictive and prognostic value of antibodies and rheumatoid factor in primary Sjögren’s syndrome. Int J Rheum Dis. 2010;13(1):39–47.

    Google Scholar 

  7. Yan SM, Zhao Y, Zeng XF, Zhang FC, Dong Y. Lung involvement of primary Sjögren’s syndrome. Zhonghua Jie He He Hu Xi Za Zhi. 2008;31:513–6.

    PubMed  Google Scholar 

  8. Shi JH, Liu HR, Xu WB, et al. Pulmonary manifestations of Sjögren’s syndrome. Respiration 2009;78:377–86.

    Article  PubMed  Google Scholar 

  9. Ye YC, Zeng Y, Zhu WL, et al. Cardiac manifestations in Sjögren’s syndrome. Zhonghua Xin Xue Buan Bing Za Zhi. 2008;36:327–31.

    Google Scholar 

  10. Mok MY, Lau CS. Protein losing enteropathy and primary Sjögren’s syndrome. Clin Exp Rheumatol. 1997;15:705.

    PubMed  CAS  Google Scholar 

  11. Nagashima T, Hoshino M, Shimoji S, et al. Protein-losing gastroenteropahy associated with primary Sjögren’s syndrome: a characteristic oriental variant. Rheumatol Int. 2009;29:817–20.

    Article  PubMed  Google Scholar 

  12. Lam CLK, Gandek B, Ren SZ, Chan MS. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 health survey. J Clin Epidemiol. 1998;51:1139–47.

    Article  PubMed  CAS  Google Scholar 

  13. Lam CLK, Launder IJ, Lam TP, Gandek B. Population based norming of the Chinese (HK) version of the SF-36 health survey. HK Pract. 1999;21:460–70.

    Google Scholar 

  14. Wong MCM, Lo ECM, McMillan AS. Validation of a Chinese version of the oral health impact profile (OHIP). Comm Dent Oral Epidemiol. 2002;30:423–30.

    Article  Google Scholar 

  15. McMillan AS, Leung KCM, Leung WK, Wong MCM, Lau CS, Mok TMY. Impact of Sjögren’s syndrome on oral health related quality of life in southern Chinese. J Oral Rehab. 2004;31:653–9.

    Article  CAS  Google Scholar 

  16. Leung KCM, McMillan AS, Leung WK, Wong MCM, Lau CS, Mok TMY. Oral condition and saliva flow in southern Chinese with Sjögren’s syndrome. Int Dent J. 2004;54:159–65.

    Article  PubMed  Google Scholar 

  17. Leung KCM, McMillan AS, Wong MCM, Leung WK, Mok MY, Lau CS. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren’s syndrome in southern Chinese patients: a randomized double-blind, placebo crossover study. Clin Rheumatol. 2008;27:429–36.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chak-sing Lau .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Lau, Cs. (2011). Sjögren’s Syndrome in China. In: Fox, R., Fox, C. (eds) Sjögren’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-60327-957-4_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-957-4_28

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-60327-956-7

  • Online ISBN: 978-1-60327-957-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics